Trial intelligence / Profile preview

Arthrosamid vs Steroid for Knee Osteoarthritis

NCT07489521Phase 4Recruiting

Sponsor
Cappagh National Orthopaedic Hospital
Start
Jan 2026
Primary completion
Sep 2027
Countries
1
01

Overview

Phase 4, randomised, single-blind trial in osteoarthritis (OA) (2 arms), sponsored by Cappagh National Orthopaedic Hospital. Primary endpoint: Western Ontario and McMaster Universities Arthritis Index at 18 months. Started Jan 2026; status: recruiting.

02

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT07489521.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07489521.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call